Orbital Therapeutics is dedicated to improving global health by maximizing the potential of RNA-based drugs to address human illnesses in unprecedented ways. The company is constructing a pioneering platform that integrates a significant variety of established and emerging technologies and delivery methods. Leveraging advanced RNA and innovative delivery technologies, Orbital is committed to advancing a comprehensive and groundbreaking portfolio of RNA therapeutics spanning various human diseases, including vaccines, immunomodulation, protein replacement, and regenerative medicine.
Orbital Therapeutics
Headquarters
United States of America